| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R.A. Wise, K. Lee. Psychomotor-stimulant sensitization: a unitary phenomenon? Behavioural pharmacology. vol 4. issue 4. 2019-11-20. PMID:11224202. |
psychomotor sensitization can be produced by direct (apomorphine, bromocriptine) and indirect (amphetamine, cocaine) dopamine agonists that inhibit the firing of dopaminergic neurons and thus reduce impulse-dependent dopamine release. |
2019-11-20 |
2023-08-12 |
Not clear |
| R.A. Wise, K. Lee. Psychomotor-stimulant sensitization: a unitary phenomenon? Behavioural pharmacology. vol 4. issue 4. 2019-11-20. PMID:11224202. |
moreover, some treatments that cause dopaminergic activation and dopamine (da)-dependent locomotion fail to cause robust psychomotor sensitization. |
2019-11-20 |
2023-08-12 |
Not clear |
| M. Morelli, S. Fenu, A. Pinna, A. Cozzolino, A. Carta, G. Di Chiar. "Priming" to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message. Behavioural pharmacology. vol 4. issue 4. 2019-11-20. PMID:11224207. |
in adult rats bearing unilateral 6-hydroxydopamine (6-ohda) lesions of the ascending dopaminergic neurons, a single administration of a dopamine (da) receptor agonist results in strong sensitization ("priming") of contralateral turning in response to d2 and particularly d1 receptor agonists. |
2019-11-20 |
2023-08-12 |
rat |
| S Ferré, P Popoli, L Giménez-Llort, R Rimondini, C E. Müller, I Strömberg, S O. Ögren, K Fux. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331192. |
evidence for a role of dopaminergic neurotransmission in the motor effects of adenosine antagonists, such as caffeine, is reviewed, based on the existence of specific antagonistic interactions between specific subtypes of adenosine and dopamine receptors in the striatum. |
2019-11-20 |
2023-08-12 |
Not clear |
| S Ferré, P Popoli, L Giménez-Llort, R Rimondini, C E. Müller, I Strömberg, S O. Ögren, K Fux. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331192. |
at least a certain degree of dopaminergic activity is required to obtain adenosine antagonist-induced motor activation, with adenosine a(1) antagonists being the most sensitive and non-selective adenosine antagonists the most resistant to striatal dopamine depletion. |
2019-11-20 |
2023-08-12 |
Not clear |
| S Raypor. Glutamate is a cotransmitter in ventral midbrain dopamine neurons. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331197. |
so it is surprising that the ventral midbrain dopamine neurons, which give rise to the dopaminergic pathway, may themselves also be glutamatergic. |
2019-11-20 |
2023-08-12 |
rat |
| S Raypor. Glutamate is a cotransmitter in ventral midbrain dopamine neurons. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331197. |
in single cell microcultures, dopamine neurons make both dopaminergic and glutamatergic synaptic varicosities. |
2019-11-20 |
2023-08-12 |
rat |
| S Raypor. Glutamate is a cotransmitter in ventral midbrain dopamine neurons. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331197. |
thus, dopamine neurons appear to exert rapid synaptic actions via their glutamatergic synapses and slower modulatory actions via their dopaminergic synapses, including possibly inhibition of their own glutamatergic synapses. |
2019-11-20 |
2023-08-12 |
rat |
| S Raypor. Glutamate is a cotransmitter in ventral midbrain dopamine neurons. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331197. |
so, in the setting of dopamine neuron demise, there will be a loss of both dopaminergic and glutamatergic inputs to the striatum; furthermore, glutamate released by dopamine neurons may contribute to an excitotoxic cascade and the death of neighboring dopamine neurons. |
2019-11-20 |
2023-08-12 |
rat |
| M von Zastro. Endocytosis and downregulation of G protein-coupled receptors. Parkinsonism & related disorders. vol 7. issue 3. 2019-11-20. PMID:11331198. |
downregulation of the number of adrenergic and dopaminergic receptors present on specific neurons can be induced by receptor agonists or by drugs that increase extracellular concentrations of catecholamines such as dopamine. |
2019-11-20 |
2023-08-12 |
Not clear |
| Ivan Berlin, Benoît de Brettes, Guy Aymard, Bertrand Diquet, Isabelle Arnulf, Alain J. Puec. Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor. The international journal of neuropsychopharmacology. vol 3. issue 1. 2019-11-20. PMID:11343576. |
dopaminergic drug response and the genotype (taq ia polymorphism) of the dopamine d2 receptor. |
2019-11-20 |
2023-08-12 |
human |
| W.-H. Wu, N.-K. Huang, C.-J. Tseng, T.-H. Yin, C.-S. Tun. Evidence that 5-HT(2) Antagonism Elicits a 5-HT(3)-Mediated Increase in Dopamine Transmission. Journal of biomedical science. vol 2. issue 2. 2019-11-20. PMID:11725054. |
the enhanced 5-ht transmission may activate postsynaptic 5-ht(3) receptors located on the dopaminergic terminals, leading to changes in dopamine transmission in these two areas. |
2019-11-20 |
2023-08-12 |
rat |
| Athanasios P. Zis, Kathleen A. McGarvey, Campbell M. Clark, Raymond W. Lam, Sara A. Adam. The Role of Dopamine in Seizure-Induced Prolactin Release in Humans. Convulsive therapy. vol 8. issue 2. 2019-11-20. PMID:11941158. |
the data suggest that the prl plasma rise after ect involves dopamine as it is not seen when the dopaminergic inhibitory tone, exerted by the hypothalamus on the pituitary lactotroph, has been removed. |
2019-11-20 |
2023-08-12 |
Not clear |
| L. Barbeito, A. Chéramy, G. Godeheu, J. M. Desce, J. Glowinsk. Glutamate Receptors of a Quisqualate-Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo. The European journal of neuroscience. vol 2. issue 4. 2019-11-20. PMID:12106037. |
in the light of previous studies, these latter observations suggest that glutamate can also exert an indirect inhibitory presynaptic influence on the release of dopamine from nerve terminals of the nigrostriatal dopaminergic neurons by acting on receptors of the quisqualate/kainate subtype located on striatal gabaergic neurons. |
2019-11-20 |
2023-08-12 |
cat |
| F. Artaud, P. Baruch, J. M. Stutzmann, M. Saffroy, G. Godeheu, L. Barbeito, D. Hervé, J. M. Studler, J. Glowinski, A. Chéram. Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat. The European journal of neuroscience. vol 1. issue 2. 2019-11-20. PMID:12106166. |
the activation of dopaminergic cells induced by the nigral application of alpha-methyl-para-tyrosine (10-4 m) stimulated the release of cck-li and dopamine in the ipsilateral caudate nucleus, whilst opposite effects were seen in the substantia nigra. |
2019-11-20 |
2023-08-12 |
cat |
| F. Artaud, P. Baruch, J. M. Stutzmann, M. Saffroy, G. Godeheu, L. Barbeito, D. Hervé, J. M. Studler, J. Glowinski, A. Chéram. Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat. The European journal of neuroscience. vol 1. issue 2. 2019-11-20. PMID:12106166. |
similar results were obtained when dopaminergic transmission was blocked in the caudate nucleus suggesting that the evoked release of cck-li by the alpha-methyl-para-tyrosine treatment originates from dopaminergic nerve terminals and not from other cck-li containing fibres in response to released dopamine. |
2019-11-20 |
2023-08-12 |
cat |
| Konrad Kohler, Reto Weile. Dopaminergic Modulation of Transient Neurite Outgrowth from Horizontal Cells of the Fish Retina is not Mediated by cAMP. The European journal of neuroscience. vol 2. issue 9. 2019-11-20. PMID:12106280. |
the formation of spinules during light adaptation requires dopaminergic activity as it does not occur in dopamine-depleted retinas, but can be partially induced in depleted retinas by the exogenous administration of dopamine. |
2019-11-20 |
2023-08-12 |
Not clear |
| M. Chritin, M. Savasta, F. Mennicken, A. Bal, D. N. Abrous, M. Le Moal, C. Feuerstein, J. P. Herma. Intrastriatal Dopamine-rich Implants Reverse the Increase of Dopamine D2 Receptor mRNA Levels Caused by Lesion of the Nigrostriatal Pathway: A Quantitative In Situ Hybridization Study. The European journal of neuroscience. vol 4. issue 7. 2019-11-20. PMID:12106330. |
moreover, grafts of embryonic dopaminergic neurons are able to modulate the expression of the dopamine d2 receptor gene. |
2019-11-20 |
2023-08-12 |
Not clear |
| P Varrial. Role of dopamine in congestive heart failure: a contemporary appraisal. Congestive heart failure (Greenwich, Conn.). vol 5. issue 3. 2019-11-20. PMID:12189316. |
the pharmacodynamic effects of dopamine, an endogenous catecholamine, are complex and mediated through selective activation of specific dopaminergic and adrenergic receptors in a dose dependent manner. |
2019-11-20 |
2023-08-12 |
Not clear |
| P Varrial. Role of dopamine in congestive heart failure: a contemporary appraisal. Congestive heart failure (Greenwich, Conn.). vol 5. issue 3. 2019-11-20. PMID:12189316. |
low dose dopamine (0.5-2 micro g/kg/min) induces intrarenal vasodilatation, augmented renal blood flow, and inhibition of renal tubular sodium reabsorption through direct stimulation of peripheral dopaminergic receptors da1 and da2. |
2019-11-20 |
2023-08-12 |
Not clear |